LYONS GARY A
SEC insider (Form 3/4/5 filer). CIK 0001123343. Director at Travere Therapeutics, Inc. (TVTX) and 1 other issuer. 22 reported Form 4/5 transactions since Sep 2024; latest on Aug 18, 2026. Located in SAN DIEGO, CA.
Companies LYONS GARY A has filed insider reports for
- Travere Therapeutics, Inc. (TVTX): Director
- NEUROCRINE BIOSCIENCES INC (NBIX): Director
LYONS GARY A
CIK: 0001123343
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (22 total)
- Aug 18, 2026TVTX
Travere Therapeutics, Inc.
ExerciseDirect5K shares at avg. $17.44$87K - Aug 18, 2026TVTX
Travere Therapeutics, Inc.
SaleDirect900 shares at avg. $63.86$57K - Aug 18, 2026TVTX
Travere Therapeutics, Inc.
SaleDirect4.1K shares at avg. $63.27$259K - Aug 17, 2026TVTX
Travere Therapeutics, Inc.
ExerciseDirect5K shares at avg. $17.44$87K - Aug 17, 2026TVTX
Travere Therapeutics, Inc.
SaleDirect500 shares at avg. $64.16$32K - Aug 17, 2026TVTX
Travere Therapeutics, Inc.
SaleDirect1.9K shares at avg. $62.53$119K - Aug 17, 2026TVTX
Travere Therapeutics, Inc.
SaleDirect2.6K shares at avg. $63.50$165K - May 27, 2026NBIX
NEUROCRINE BIOSCIENCES INC
AwardDirectNon-Qualified Stock Option
2.6K shares- - May 27, 2026NBIX
NEUROCRINE BIOSCIENCES INC
AwardDirectRestriced Stock Unit
1.3K shares- - May 21, 2026NBIX
NEUROCRINE BIOSCIENCES INC
ExerciseDirect1.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 18, 2026 |  TVTX Travere Therapeutics, Inc. | Exercise | 5,000 | $17.44 | $87,200 | Direct |
| Aug 18, 2026 | TVTX Travere Therapeutics, Inc. | Sale | 900 | $63.86 | $57,470 | Direct |
| Aug 18, 2026 | TVTX Travere Therapeutics, Inc. | Sale | 4,100 | $63.27 | $259,390 | Direct |
| Aug 17, 2026 | TVTX Travere Therapeutics, Inc. | Exercise | 5,000 | $17.44 | $87,200 | Direct |
| Aug 17, 2026 | TVTX Travere Therapeutics, Inc. | Sale | 500 | $64.16 | $32,081 | Direct |
| Aug 17, 2026 | TVTX Travere Therapeutics, Inc. | Sale | 1,900 | $62.53 | $118,805 | Direct |
| Aug 17, 2026 | TVTX Travere Therapeutics, Inc. | Sale | 2,600 | $63.50 | $165,100 | Direct |
| May 27, 2026 |  NBIX NEUROCRINE BIOSCIENCES INC | Award Non-Qualified Stock Option | 2,624 | - | - | Direct |
| May 27, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Award Restriced Stock Unit | 1,284 | - | - | Direct |
| May 21, 2026 | NBIX NEUROCRINE BIOSCIENCES INC | Exercise | 1,659 | - | $0 | Direct |
1-10 of 22 transactions